quinuclidines has been researched along with methoctramine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McLeskey, SW; Wojcik, WJ | 1 |
Ohno, M; Watanabe, S; Yamamoto, T | 1 |
Costa, E; de Erausquin, G; Fohrman, EB; Wojcik, WJ | 1 |
Amari, G; Bassani, F; Battipaglia, L; Bergamaschi, M; Berti, F; Bolzoni, PT; Cacciani, F; Cenacchi, V; Civelli, M; Delcanale, M; Geppetti, PA; Harrison, S; Mannini, F; Pastore, F; Patacchini, R; Petrillo, P; Razzetti, R; Rizzi, A; Rossoni, G; Santoro, E; Scudellaro, R; Villetti, G; Volta, R; Zaniboni, M | 1 |
Chess-Williams, R; Moro, C; Uchiyama, J | 1 |
5 other study(ies) available for quinuclidines and methoctramine
Article | Year |
---|---|
Identification of muscarinic receptor subtypes present in cerebellar granule cells: prevention of [3H]propylbenzilyl choline mustard binding with specific antagonists.
Topics: Adenylyl Cyclase Inhibitors; Animals; Atropine; Cell Membrane; Cells, Cultured; Cerebellum; Diamines; Electrophoresis, Polyacrylamide Gel; Parasympatholytics; Pirenzepine; Propylbenzilylcholine Mustard; Quinuclidines; Receptors, Muscarinic; Xanthenes | 1990 |
Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats.
Topics: Animals; Conditioning, Operant; Diamines; Dose-Response Relationship, Drug; Hippocampus; Injections; Male; Memory, Short-Term; Muscarinic Agonists; Muscarinic Antagonists; Parasympatholytics; Parasympathomimetics; Pirenzepine; Psychomotor Performance; Quinuclidines; Rats; Rats, Wistar; Thiophenes | 1994 |
Muscarinic m3 receptors and dynamics of intracellular Ca2+ cerebellar granule neurons.
Topics: Animals; Calcium; Carbachol; Cells, Cultured; Cerebellum; Dantrolene; Diamines; Fura-2; Glutamates; Glutamic Acid; Microscopy, Fluorescence; Neurons; Parasympatholytics; Quinuclidines; Rats; Receptors, Glutamate; Receptors, Muscarinic; Terpenes; Thapsigargin; Xanthenes | 1993 |
Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Topics: Acetylcholine; Aged; Anesthesia; Animals; Blood Pressure; Bronchi; Bronchial Spasm; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Carbachol; Carbamates; CHO Cells; Cricetinae; Cricetulus; Diamines; Guinea Pigs; Heart Atria; Heart Rate; Humans; Kinetics; Male; Middle Aged; Molecular Structure; Muscarinic Antagonists; Myocardial Contraction; Quinuclidines; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Scopolamine Derivatives; Tiotropium Bromide; Trachea; Transfection; Ventricular Function, Left | 2010 |
Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzofurans; Carbachol; Cresols; Diamines; Mandelic Acids; Mucous Membrane; Muscarinic Antagonists; Muscle Contraction; Phenylpropanolamine; Piperidines; Pirenzepine; Pyrrolidines; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Stress, Mechanical; Swine; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urothelium | 2011 |